Effects of colchicine on renal fibrosis and apoptosis in obstructed kidneys
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Colchicine is an established drug for microtubule stabilization that may reduce tissue injury. No data were available that its effects may depend on the dosage of colchicine. We investigated the anti-fibrotic and apoptotic effects of various dose of colchicine in a unilateral ureteral obstruction (UUO) model. Methods: Thirty-six Sprague-Dawley rats were randomly assigned into six groups. Two sham groups were divided into a vehicle-treated or colchicine-treated group (100 μg/kg/day). Four UUO groups were treated with either vehicle or three different doses of colchicine for 7 days (30, 60, and 100 μg/kg/day, intraperitoneally). All of the animals were sacrificed on day 7. Results: Colchicine treatment diminished acetylated α-tubulin and tumor growth factor-β immunoreactivities in the cortical area of the 7-day obstructed kidneys, which was in dose dependent manner. Colchicine attenuated tubulointerstitial damage and apoptosis in both cortical and medullary area, and beneficial effects of colchicine therapy were dramatically shown at the higher dosage of colchicine. The expression levels of cleaved caspase-3, ED-1, and fibronectin were decreased in UUO animals. Conclusions: We found that the proper dosage of colchicine may have anti-fibrotic and anti-apoptotic effects in obstructed kidneys. For clinical applications, an optimal dose of colchicine should be evaluated to maximize the prevention of renal disease progression.
Abstract
Background/Aims: Colchicine is an established drug for microtubule stabilization that may reduce tissue injury. No data were available that its effects may depend on the dosage of colchicine. We investigated the anti-fibrotic and apoptotic effects of various dose of colchicine in a unilateral ureteral obstruction (UUO) model. Methods: Thirty-six Sprague-Dawley rats were randomly assigned into six groups. Two sham groups were divided into a vehicle-treated or colchicine-treated group (100 μg/kg/day). Four UUO groups were treated with either vehicle or three different doses of colchicine for 7 days (30, 60, and 100 μg/kg/day, intraperitoneally). All of the animals were sacrificed on day 7. Results: Colchicine treatment diminished acetylated α-tubulin and tumor growth factor-β immunoreactivities in the cortical area of the 7-day obstructed kidneys, which was in dose dependent manner. Colchicine attenuated tubulointerstitial damage and apoptosis in both cortical and medullary area, and beneficial effects of colchicine therapy were dramatically shown at the higher dosage of colchicine. The expression levels of cleaved caspase-3, ED-1, and fibronectin were decreased in UUO animals. Conclusions: We found that the proper dosage of colchicine may have anti-fibrotic and anti-apoptotic effects in obstructed kidneys. For clinical applications, an optimal dose of colchicine should be evaluated to maximize the prevention of renal disease progression.
참고문헌 (28)
- 김성국, "The colchicine derivative CT20126 shows a novel microtubule-modulating activity with apoptosis", Experimental and Molecular Medicine, 45(4), pp.1~7 (2013), 생화학분자생물학회
- Mollinedo F, "Survival and apoptotic signals in the action of microtubule-targeting antitumor drugs", IDrugs, 8, pp.127~143 (2005)
- McClurkin C Jr, "Moderate protection of renal function and reduction of fibrosis by colchicine in a model of anti-GBM disease in the rabbit", J Am Soc Nephrol, 1, pp.257~265 (1990)
- Li C, "Colchicine decreases apoptotic cell death in chronic cyclosporine nephrotoxicity", J Lab Clin Med, 139, pp.364~371 (2002)[DOI]
- Li JJ, "Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy", Am J Physiol Renal Physiol, 297, pp.F200~F209 (2009)[DOI]
- Guan T, "Colchicine attenuates renal injury in a model of hypertensive chronic kidney disease", Am J Physiol Renal Physiol, 305, pp.F1466~F1476 (2013)[DOI]
- Wilson DR, "Nephron functional heterogeneity in the postobstructive kidney", Kidney Int, 7, pp.19~26 (1975)[DOI]
- Mason J, "Disparity between surface and deep nephron function early after renal ischemia", Kidney Int, 24, pp.27~36 (1983)[DOI]
- Gobe GC, "Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis", Lab Invest, 56, pp.273~281 (1987)
- Truong LD, "Renal cell apoptosis in chronic obstructive uropathy: the roles of caspases", Kidney Int, 60, pp.924~934 (2001)[DOI]
- Yutao X, "Mechanical stretch-induced hypertrophy of neonatal rat ventricular myocytes is mediated by beta(1)-integrin-microtubule signaling pathways", Eur J Heart Fail, 8, pp.16~22 (2006)[DOI]
- Kim S, "Changes in the sodium and potassium transporters in the course of chronic renal failure", Nephron Physiol, 115, pp.31~41 (2010)[DOI]
- Na KY, "Chronic furosemide or hydrochlorothiazide administration increases H+-ATPase B1 subunit abundance in rat kidney", Am J Physiol Renal Physiol, 292, pp.F1701~F1709 (2007)[DOI]
- Gourlay CW, "The actin cytoskeleton: a key regulator of apoptosis and ageing?", Nat Rev Mol Cell Biol, 6, pp.583~589 (2005)
- Jung HI, "Colchicine activates actin polymerization by microtubule depolymerization", Mol Cells, 7, pp.431~437 (1997)
- Disel U, "Effect of colchicine on cyclosporine nephrotoxicity, reduction of TGF-beta overexpression, apoptosis, and oxidative damage: an experimental animal study", Transplant Proc, 36, pp.1372~1376 (2004)[DOI]
- El-Sakka AI, "The effects of colchicine on a Peyronie's-like condition in an animal model", J Urol, 161, pp.1980~1983 (1999)[DOI]
- Shan B, "Requirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition", J Biol Chem, 283, pp.21065~21073 (2008)[DOI]
- Serrador JM, "HDAC6 deacetylase activity links the tubulin cytoskeleton with immune synapse organization", Immunity, 20, pp.417~428 (2004)[DOI]
- Ruwhof C, "Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways", Cardiovasc Res, 47, pp.23~37 (2000)[DOI]
- Stone AA, "Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells", Exp Cell Res, 254, pp.110~119 (2000)[DOI]
- Masaki T, "Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney", Kidney Int, 63, pp.1256~1264 (2003)[DOI]
- Tao Y, "Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease", Proc Natl Acad Sci U S A, 102, pp.6954~6959 (2005)[DOI]
- Zhou B, "Microtubule involvement in translational regulation of fibronectin expression by light chain 3 of microtubule-associated protein 1 in vascular smooth muscle cells", Circ Res, 83, pp.481~489 (1998)[DOI]
- Park SH, "Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition", J Am Soc Nephrol, 18, pp.1497~1507 (2007)[DOI]
- Chevalier RL, "Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy", Kidney Int, 75, pp.1145~1152 (2009)[DOI]
- 권태환, "Regulation of aquaporin-2 in the kidney: A molecular mechanism of body-water homeostasis", Kidney Research and Clinical Practice, 32(3), pp.96~102 (2013), 대한신장학회
- 강석휘, "Biopsy-Proven Type 1 Renal Tubular Acidosis in a Patient with Metabolic Acidosis", The Korean Journal of Internal Medicine, 27(1), pp.119~119 (2012), 대한내과학회